English
Home > Products > 4-Benzyl-2-hydroxy-morpholin-3-one

China 4-Benzyl-2-hydroxy-morpholin-3-one Factory

Our pursuit and corporation intention is to "Always satisfy our client requirements". We continue to develop and style remarkable high-quality items for each our outdated and new shoppers and accomplish a win-win prospect for our customers likewise as us for 4-Benzyl-2-hydroxy-morpholin-3-one,CAS NO 287930-73-8,287930-73-8,Aprepitant intermediate,Aprepitant advance intermediate, Welcome to setup long-term romantic relationship with us. Best Value Permanently Top quality in China.
4-Benzyl-2-hydroxy-morpholin-3-one, We are eager to cooperate with foreign companies which care much on the real quality, stable supply, strong capability and good service. We can offer the most competitive price with high quality,because we are much MORE PROFESSIONAL. You are welcomed to visit our company at any time.

Related Products

Hot Products

  • Fipronil

    Fipronil

    Product Name:Fipronil
    Molecular Formula:C12H4Cl2F6N4OS
    Molecular Weight;437.15
    CAS Registry Number;120068-37-3
  • 4-Amino-2-chloropyridine

    4-Amino-2-chloropyridine

    Product Name:4-Amino-2-chloropyridine
    Molecular Formula:C5H5ClN2
    Molecular Weight:128.56
    CAS Registry Number:14432-12-3
  • L-Malic acid

    L-Malic acid

    Product Name:L-Malic acid
    Molecular Formula:C4H6O5
    Molecular Weight:134.09
    CAS Registry Number:97-67-6
  • Salicylic Acid

    Salicylic Acid

    Product Name:Salicylic Acid
    Molecular Weight:138.12
    CAS Registry Number:69-72-7
  • (R)-3-(Boc-Amino)Piperidine

    (R)-3-(Boc-Amino)Piperidine

    (R)-3-(Boc-Amino)Piperidine
    CAS NO：309956-78-3
    Molecular Formula:C₁₀H₂₀N₂O₂
    Molecular Weight:200.28
    Usage:Linagliptin Intermediates
  • Travoprost

    Travoprost

    Product Name:Travoprost
    Molecular Formula:C26H35F3O6
    Molecular Weight:500.55
    CAS Registry Number:157283-68-6
  • Related Blog
  • Reviews

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

  • How is a drug produced?

    ​There are so many different drugs ,with different color /shape ( like capsule ,tablet or Infusion) and price . Here we would like to explain , what makes it so different? How is a drug produced?

  • Baloxavir marboxil

    Baloxavir marboxil is used to treat flu symptoms caused by influenza virus in people who have had symptoms for no more than 48 hours. Baloxavir marboxil will not treat the common cold. Baloxavir marboxil is for adults and children who are at least 12 years old and weigh at least 88 pounds (40 kilograms).

  • Tofacitinib More Effective, Alone and in Combinations, than Non-biologic DMARDS

    Tofacitinib (marketed under the brand name Xeljanz) is an oral Janus kinase inhibitor currently approved for the treatment of RA. It was developed in a unique public-private partnership between the National Institutes of Health...

  • CAS No. 144689-24-7 Olmesartan Introduction

    Olmesartan is an angiotensin II receptor blocker, widely used for the treatment of hypertension. The Renin-Angiotensin-Aldosterone System (RAAS) plays an importent role in the development and progression of many diseases such as hypertension...

  • CAS 148553-50-8 What is Pregabalin?

    Pregabalin is an anti-epileptic drug, also called an anticonvulsant. It works by slowing down impulses within the brain that cause seizures. Pregabalin also affects chemicals within the brain that send pain signals across the systema nervosum.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept